JW Lifescience Corporation (234080.KS) KSC
13,140.00
-80(-0.61%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
13,140.00
-80(-0.61%)
Currency In KRW
| Market Cap | 198.49B |
| Enterprise Value | 198.49B |
| P/E Ratio | 7.06 |
| PEG Ratio | -0.18 |
| Price/Sales Ratio | 0.79 |
| Price/Book Ratio | 0.94 |
| Enterprise/Revenue | 0.96 |
| Enterprise/EBITDA | -2.24 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0.11 |
| Operating Margin | -0.52 |
| Return On Assets | 0.09 |
| Return On Equity | 0.14 |
| Revenue | 257.83B |
| Revenue/Share | 16,691.23 |
| Gross Profit | 0 |
| EBITDA | 33.3B |
| Net Income | 28.75B |
| Diluted EPS | 1,815.81 |
| Total Cash | 25.8B |
| Total Cash/Share | 1,669.91 |
| Total Debt | 49.96B |
| Total Debt/Equity | 0.23 |
| Current Ratio | 1.21 |
| Book Value Per Share | 13,909.21 |
| 52-Week Change | 15.98 |
| 52-Week High | 15,580 |
| 52-Week Low | 10,420 |
| Moving Average 50 Days | 12,929 |
| Moving Average 200 Days | 12,860.1 |
| Average Volume | 60,742 |
| Shares Outstanding | 15.48M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.27 |
| Last Split Factor | 2:1 |
| Last Split Date | May 15, 2018 |